Photoreactive polymer and alignment layer comprising the same

ABSTRACT

Disclosed herein are a photoreactive polymer, and an alignment layer comprising the same that exhibit excellences in alignment rate and alignment stability. The photoreactive polymer comprises a cyclic olefin-based repeating unit with at least one photoreactive substituent, and the maximum absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm 2 ) upon exposure to a polarized UV radiation having a wavelength of 150 to 450 nm at a total exposure dose of 20 mJ/cm 2  or less is at least 0.003.

This application is a Utility Application and claims priority to and the benefit of Korean Patent Application Nos. 10-2010-0093180, filed on Sep. 27, 2010, and 10-2011-0054367, filed on Jun. 7, 2011, which are hereby incorporated by reference in their entirety for all purposes as if fully set forth herein.

FIELD OF THE INVENTION

The present invention relates to a photoreactive polymer and an alignment layer comprising the same and, more particularly, to a photoreactive polymer and an alignment layer comprising the same that exhibit excellences in alignment rate and alignment stability.

BACKGROUND ART

With a recent advent of large-sized LCDs and a gradual expansion of their usage from portable devices, such as mobile phones, lap-top computers, etc., to home appliances, such as wall mounted flat panel TVs, there is a demand for LCDs with high definition and wide viewing angle. In particular, TFT-driven thin film transistor LCDs (TFT-LCDs) of which each pixel is independently driven are much superior in response speed of liquid crystals, realizing high-definition motion pictures, and thus increasingly used in a wider range of applications.

To be used as optical switches in the TFT-LCDs, liquid crystals are required to be initially aligned in a defined direction on a layer including innermost TFT of the display cell. For this, a liquid crystal alignment layer is used.

For the liquid crystal alignment to occur, a heat-resistant polymer such as polyimide is applied on a transparent glass to form a polymer alignment layer, which is then subjected to a rubbing process using a rotary roller wound with a rubbing cloth of nylon or rayon fabrics at a high rotation speed to align liquid crystals.

However, the rubbing process remains mechanical scratches on the surface of the liquid crystal alignment layer or generates strong static electricity, possibly destroying the TFTs. Further, fine fibers coming from the rubbing cloth may cause defectives, which become an obstacle to acquiring a higher production yield.

To overcome the problems with the rubbing process and achieve innovation in the aspect of production yield, there has been derived a liquid crystal alignment method using a light such as UV radiation (hereinafter, referred to as “photo-alignment”).

Photo-alignment refers to the mechanism using a linearly polarized UV radiation to cause the photoreactive groups of a defined photoreactive polymer to participate in a photoreaction, aligning the main chain of the polymer in a defined direction to form a photo-polymerized liquid crystal alignment layer with aligned liquid crystals.

The representative example of the photo-alignment is photopolymerization-based photo-alignment as disclosed by M. Schadt et al. (Jpn. J. Appl. Phys., Vol 31, 1992, 2155), Dae S. Kang et al. (U.S. Pat. No. 5,464,669), and Yuriy Reznikov (Jpn. J. Appl. Phys. Vol. 34, 1995, L1000). The photo-aligned polymers used in these patent and research papers are mostly polycinnamate-based polymers, such as poly(vinylcinnamate) (PVCN) or poly(vinyl methoxycinnamate) (PVMC). For photo-alignment of polymers, the double bond of cinnamate exposed to UV radiation participates in a [2+2] cycloaddition reaction to form cyclobutane, which provides anisotropy to cause liquid crystal molecules aligned in one direction, inducing liquid crystal alignment.

Besides, JP11-181127 discloses a polymer and an alignment layer including the same in which the polymer has a side chain including photoreactive groups such as cinnamate on a main chain such as acrylate, methacrylate, etc. Korean Patent Laid-Open Publication No. 2002-0006819 also discloses the use of an alignment layer comprising a polymethacryl-based polymer.

However, the above-mentioned conventional photoreactive polymers for alignment layer have a low thermal stability of the polymer main chain, undesirably deteriorating the stability of the alignment layer or providing poor characteristics in regard to photoreactivity, liquid crystal alignment, or alignment rate. Particularly, the initial alignment rate after irradiation is not high enough, causing a deterioration in the economical efficiency of the process, and the alignment characteristic is ready to change after a defined period of time under irradiation to deteriorate the alignment stability. Consequently, it is difficult not only to provide the final alignment layer with a uniform alignment characteristic but to efficiently acquire the alignment layer having a desired good alignment characteristic.

SUMMARY OF THE INVENTION

The present invention provides a photoreactive polymer having excellences in alignment rate and alignment stability.

The present invention also provides an alignment layer and a display device that comprise the photoreactive polymer.

The present invention provides a photoreactive polymer that comprises a cyclic olefin-based repeating unit with at least one photoreactive substituent and is at least 0.003 in the maximum absolute value of a variation in dichloric ratio per unit UV dose (mJ/cm²) as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to a polarized UV radiation having a wavelength of 150 to 450 nm at a total exposure dose of 20 mJ/cm² or less.

As for the photoreactive polymer, the absolute value of a variation in dichloric ratio per unit UV dose (mJ/cm²) as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to a polarized UV radiation at a total exposure dose of 500 mJ/cm² or more may be in the range of 0 to 0.00006.

In the photoreactive polymer, the cyclic olefin-based repeating unit may comprise a repeating unit of the following formula 3a or 3b:

In the formulas 3a and 3b, independently, m is 50 to 5,000; q is an integer from 0 to 4; and at least one of R1, R2, R3 and R4 is any one selected from the group consisting of radicals represented by the following formula 1a or 1b. Among the R1 to R4, the remainders other than the radical of the formula 1a or 1b are the same as or different from one another and independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted linear or branched alkyl having 1 to 20 carbon atoms; substituted or unsubstituted linear or branched alkenyl having 2 to 20 carbon atoms; substituted or unsubstituted linear or branched alkynyl having 2 to 20 carbon atoms; substituted or unsubstituted cycloalkyl having 3 to 12 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; and a polar functional group comprising at least one of oxygen, nitrogen, phosphor, sulfur, silicon, and boron. When the R1 to R4 are not hydrogen, halogen, or a polar functional group, at least one of a R1 and R2 coordination and a R3 and R4 coordination is bonded to each other to form an alkylidene group having 1 to 10 carbon atoms; or R1 or R2 is bonded to either R3 or R4 to form a saturated or unsaturated aliphatic ring having 4 to 12 carbon atoms or an aromatic ring having 6 to 24 carbon atoms.

In the formulas 1a and 1b, A is chemical bond, oxygen, sulfur, or —NH—. B is selected from the group consisting of chemical bond, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, carbonyl, carboxy, ester, substituted or unsubstituted arylene having 6 to 40 carbon atoms, and substituted or unsubstituted heteroarylene having 6 to 40 carbon atoms; X is oxygen or sulfur; R9 is selected from the group consisting of chemical bond, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, substituted or unsubstituted alkenylene having 2 to 20 carbon atoms, substituted or unsubstituted cycloalkylene having 3 to 12 carbon atoms, substituted or unsubstituted arylene having 6 to 40 carbon atoms, substituted or unsubstituted aralkylene having 7 to 15 carbon atoms, and substituted or unsubstituted alkynylene having 2 to 20 carbon atoms. At least one of R10 to R14 is a radical represented by -L-R15-R16- (substituted or unsubstituted C6-C40 aryl). Among the R10 to R14, the remainders other than the radical of -L-R15-R16- (substituted or unsubstituted C6-C40 aryl) are the same as or different from one another and independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted alkyl having 1 to 20 carbon atoms; substituted or unsubstituted alkoxy having 1 to 20 carbon atoms; substituted or unsubstituted aryloxy having 6 to 30 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; and heteroaryl having 6 to 40 carbon atoms with a hetero element in Group 14, 15 or 16. L is selected from the group consisting of oxygen, sulfur, —NH—, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, carbonyl, carboxy, —CONH—, and substituted or unsubstituted arylene having 6 to 40 carbon atoms. R15 is substituted or unsubstituted alkyl having 1 to 10 carbon atoms. R16 is selected from the group consisting of chemical bond, —O—, —C(═O)O—, —OC(═O)—, —NH—, —S—, and —C(═O)—.

The present invention also provides an alignment layer comprising the photoreactive polymer.

The present invention also provides a display device comprising the alignment layer.

The photoreactive polymer of the present invention is far superior in the initial alignment rate to the conventional photoreactive polymers and not ready to change significantly in the alignment characteristic under exposure to a UV radiation at a relatively great exposure dose for more than a defined period of time, thereby securing good alignment stability.

Hence, the use of the photoreactive polymer may efficiently provide an alignment layer having a desired good alignment characteristic with uniformity.

Accordingly, the photoreactive polymer can be preferably used as a photo-aligned polymer in various coating compositions and alignment layers formed from the coating compositions applicable to various LCD devices, and the alignment layer comprising the photoreactive polymer may have excellent characteristics.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic diagram showing an exemplary structure of a general alignment layer.

FIG. 2 is a graph showing the change of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) for the photoreactive polymers of examples and comparative examples under exposure to a UV radiation at a total exposure dose of 250 mJ/cm² or less in the experimental example.

FIG. 3 is a graph showing the change of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) for the photoreactive polymers of examples and comparative examples under exposure to a UV radiation at a total exposure dose of 500 mJ/cm² or more in the experimental example.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Hereinafter, a detailed description will be given as to a photoreactive polymer and an alignment layer according to embodiments of the invention.

In accordance with one embodiment of the present invention, there is provided a photoreactive polymer that comprises a cyclic olefin-based repeating unit with at least one photoreactive substituent and is at least 0.003 in the maximum absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to a polarized UV radiation having a wavelength of 150 to 450 nm at a total exposure dose of 20 mJ/cm² or less.

The photoreactive polymer according to one embodiment of the present invention, upon exposure to a polarized UV radiation having a defined wavelength, may have the dichloric ratio even abruptly changing even at a relatively low exposure dose of the polarized UV radiation. Such an exposure to a polarized radiation at a low exposure dose for a short period of time may also result in a rapid change of the dichloric ratio, which reflects the alignment characteristic, so the maximum absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) is abruptly increased up to at least about 0.003, preferably about 0.003 to 0.008, more preferably about 0.005 to 0.008 within a short period of time. In contrast, the conventional photoreactive polymers are mostly less than about 0.002 or 0.003 in the maximum absolute value of the variation, d(dichloric ratio)/d(mJ/cm²), and far inferior in the change rate of the dichloric ratio to the photoreactive polymer of the present invention.

Contrarily, the photoreactive polymer according to one embodiment of the present invention undergoes photo-alignment at a very high rate upon exposure to a polarized UV radiation, within a short period of time at a low exposure dose relative to any conventional photoreactive polymers. Hence, the use of the photoreactive polymer with such a high alignment rate may efficiently provide an alignment layer having a desired alignment characteristic.

More specifically, as for the photoreactive polymer according to one embodiment of the present invention, the absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to a polarized UV radiation having a wavelength of 150 to 450 nm at a total exposure dose of 20 mJ/cm² may amount to about 0.003 to 0.008, preferably about 0.005 to 0.008. In other words, the photoreactive polymer, upon exposure to a polarized UV radiation for a relatively short period of time at a total exposure dose of 20 mJ/cm², may be at least about 0.003 in the absolute value of d(dichloric ratio)/d(mJ/cm²), consequently with an abrupt change in the dichloric ratio. As a result, the photoreactive polymer undergoes photo-alignment at a very high rate upon exposure to a polarized UV radiation to very efficiently form an alignment layer having a desired alignment characteristic.

Also, the photoreactive polymer, under exposure to the polarized UV radiation at a total exposure dose of 500 mJ/cm² or more, may have the absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) in the range of about 0 to 0.00006, preferably about 0 to 0.00002. More specifically, at a total exposure dose of 500 to 2,500 mJ/cm², the absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) may range from about 0 to 0.00006, preferably about 0 to 0.00002.

Such a photoreactive polymer may show a desired alignment characteristic stably maintained even when the total exposure dose of the polarized UV radiation amounts to about 500 mJ/cm² or more, for example, about 500 to 2,500 mJ/cm² after a long-term irradiation. This implies the fact that the photoreactive polymer can maintain an alignment characteristic with high stability once the alignment characteristic comes to a defined level rapidly in the early stage of exposure. Hence, the use of the photoreactive polymer makes it possible to provide an alignment layer with a high alignment stability. In other words, the desired alignment characteristic, once acquired, can be stably maintained without a change even when the conditions for the photo-alignment process are changed, so the use of the photoreactive polymer may provide an alignment layer having a desired alignment characteristic uniformly in a stable and efficient way.

On the other hand, the above-described characteristic related to a variation in the dichloric ratio per unit exposure dose (mJ/cm²), which has never been offered by the conventional photoreactive polymers, may be acquired using the photoreactive polymer obtained from the novel cyclic olefin compound.

Hereinafter, a detailed description will be given as to the cyclic olefin compound, the photoreactive polymer, and a preparation method for the same.

The characteristics of the photoreactive polymer according to one embodiment of the present invention may be acquired from a photoreactive polymer obtained from a cyclic olefin compound having a photoreactive group of the following formula 1 used as a monomer:

In the formula 1, q is an integer from 0 to 4; and at least one of R1, R2, R3 and R4 is any one selected from the group consisting of radicals of the following formula 1a and 1b. Among the R1 to R4, the remainders other than the radical of the formula 1a or 1b are the same as or different from one another and independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted linear or branched alkyl having 1 to 20 carbon atoms; substituted or unsubstituted linear or branched alkenyl having 2 to 20 carbon atoms; substituted or unsubstituted linear or branched alkynyl having 2 to 20 carbon atoms; substituted or unsubstituted cycloalkyl having 3 to 12 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; and a polar functional group comprising at least one of oxygen, nitrogen, phosphor, sulfur, silicon, and boron. When the R1 to R4 are not hydrogen, halogen, or a polar functional group, at least one of a R1 and R2 coordination and a R3 and R4 coordination is bonded to each other to form an alkylidene group having 1 to 10 carbon atoms; or R1 or R2 is bonded to either R3 or R4 to form a saturated or unsaturated aliphatic ring having 4 to 12 carbon atoms or an aromatic ring having 6 to 24 carbon atoms.

In the formula 1a or 1b, A is chemical bond, oxygen, sulfur, or —NH—. B is selected from the group consisting of chemical bond, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, carbonyl, carboxy, ester, substituted or unsubstituted arylene having 6 to 40 carbon atoms, and substituted or unsubstituted heteroarylene having 6 to 40 carbon atoms. X is oxygen or sulfur. R9 is selected from the group consisting of chemical bond, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, substituted or unsubstituted alkenylene having 2 to 20 carbon atoms, substituted or unsubstituted cycloalkylene having 3 to 12 carbon atoms, substituted or unsubstituted arylene having 6 to 40 carbon atoms, substituted or unsubstituted aralkylene having 7 to 15 carbon atoms, and substituted or unsubstituted alkynylene having 2 to 20 carbon atoms. At least one of R10 to R14 is a radical represented by -L-R15-R16- (substituted or unsubstituted C6-C40 aryl). Among the R10 to R14, the remainders other than the radical of -L-R15-R16- (substituted or unsubstituted C6-C40 aryl) are the same as or different from one another and independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted alkyl having 1 to 20 carbon atoms; substituted or unsubstituted alkoxy having 1 to 20 carbon atoms; substituted or unsubstituted aryloxy having 6 to 30 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; and heteroaryl having 6 to 40 carbon atoms with a hetero element in Group 14, 15 or 16. L is selected from the group consisting of oxygen, sulfur, —NH—, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, carbonyl, carboxy, —CONH—, and substituted or unsubstituted arylene having 6 to 40 carbon atoms. R15 is substituted or unsubstituted alkyl having 1 to 10 carbon atoms. R16 is selected from the group consisting of chemical bond, —O—, —C(═O)O—, —OC(═O)—, —NH—, —S—, and —C(═O)—.

In such a cyclic olefin compound, the radical of -L-R15-R16- (substituted or unsubstituted C6-C40 aryl) may be represented by the following formula 2, where the linker L is oxygen and the aryl is phenyl; or may be any radical having a different aryl and a different linker L:

In the formula 2, R15 and R16 are as defined in formula 1; and R17 to R21 are the same as or different from one another and independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted alkyl having 1 to 20 carbon atoms; substituted or unsubstituted alkoxy having 1 to 20 carbon atoms; substituted or unsubstituted aryloxy having 6 to 30 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; heteroaryl having 6 to 40 carbon atoms with a hetero element in Group 14, 15 or 16; and substituted or unsubstituted alkoxyaryl having 6 to 40 carbon atoms.

Such a compound has a chemical structure in which the ends of photoreactive groups such as cinnamate are bonded to a substituent represented by -L-R15-R16- (substituted or unsubstituted C6-C40 aryl). The substituent comprises an aralkyl structure that alkyl and aryl groups are sequentially connected together via a linker L. Such a bulky chemical structure as aralkyl is connected to the ends of photoreactive groups via a linker L, confirming the formation of a large free volume between the photoreactive groups. This seems likely to be caused by the steric hindrance between adjacent bulky aralkyl structures.

For this reason, photoreactive groups such as cinnamate in the photoreactive polymer and the alignment layer prepared using the cyclic olefin compound are relatively free to move (flow) or react in such a large free volume, minimizing hindrance from other reactors or substituents. Consequently, the photoreactive groups in the photoreactive polymer and the alignment layer can have excellences in photoreactivity, alignment rate, and photo-alignment. Especially, photoreactive groups such as cinnamate undergo photo-alignment, which takes place as a simultaneous occurrence of dimerization and isomerization caused by polarized radiation. The photo-alignment occurs more easily and rapidly without any hindrance in the large free volume. Further, once the photo-alignment occurs, the desired photo-alignment characteristic can be maintained stably without any hindrance from other photoreactive groups, or the like.

Accordingly, the photoreactive polymer prepared from the cyclic olefin compound is enabled to realize the characteristics of the embodiment of the present invention and have better excellences in alignment rate and alignment stability.

In the cyclic olefin compound, a polar functional group used as a substituent for the R1 to R4, that is, a polar functional group including at least one of oxygen, nitrogen, phosphor, sulfur, silicon, and boron may be selected from the group consisting of the following functional groups, or otherwise, comprise at least one of oxygen, nitrogen, phosphor, sulfur, silicon, and boron:

—OR₆, —OC(O)OR₆, —R₅OC(O)OR₆, —C(O)OR₆, —R₅C(O)OR₆, —C(O)R₆, —R₅C(O)R₆, —OC(O)R₆, —R₅OC(O)R₆, —(R₅O)p-OR₆, —(OR₅)p-OR₆, —C(O)—O—C(O)R₆, —R₅C(O)—O—C(O)R₆, —SR₆, —R₅SR₆, —SSR₆, —R₅SSR₆, —S(═O)R₆, —R₅S(═O)R₆, —R₅C(═S)R₆—, —R₅C(═S)SR₆, —R₅SO₃R₆, —SO₃R₆, —R₅N═C═S, —N═C═S, —NCO, —R₅—NCO, —CN, —R₅CN, —NNC(═S)R₆, —R₅NNC(═S)R₆, —NO₂, —R₅NO₂,

In the polar functional groups, independently, p is an integer from 1 to 10. R5 is substituted or unsubstituted linear or branched alkylene having 1 to 20 carbon atoms; substituted or unsubstituted linear or branched alkenylene having 2 to 20 carbon atoms; substituted or unsubstituted linear or branched alkynylene having 2 to 20 carbon atoms; substituted or unsubstituted cycloalkylene having 3 to 12 carbon atoms; substituted or unsubstituted arylene having 6 to 40 carbon atoms; substituted or unsubstituted carbonyloxylene having 1 to 20 carbon atoms; or substituted or unsubstituted alkoxylene having 1 to 20 carbon atoms. R6, R7 and R8 are independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted linear or branched alkyl having 1 to 20 carbon atoms; substituted or unsubstituted linear or branched alkenyl having 2 to 20 carbon atoms; substituted or unsubstituted linear or branched alkynyl having 2 to 20 carbon atoms; substituted or unsubstituted cycloalkyl having 3 to 12 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; substituted or unsubstituted alkoxy having 1 to 20 carbon atoms; and substituted or unsubstituted carbonyloxy having 1 to 20 carbon atoms.

In the cyclic olefin compound, the substituted or unsubstituted aryl having 6 to 40 carbon atoms or the heteroaryl having 6 to 40 carbon atoms with an hetero element in Group 14, 15 or 16 is selected from the group consisting of the following functional groups; or may be other different aryl or heteroaryl groups:

In the functional groups, R□10 to R□18 are the same as or different from one another and independently selected from the group consisting of substituted or unsubstituted linear or branched alkyl having 1 to 20 carbon atoms; substituted or unsubstituted alkoxy having 1 to 20 carbon atoms; substituted or unsubstituted aryloxy having 6 to 30 carbon atoms; and substituted or unsubstituted aryl having 6 to 40 carbon atoms.

In the cyclic olefin compound, at least one of the R1 to R4 of the formula 1 is a photoreactive group of the formula 1a or 1b. For example, at least one of R1 and R2 may be the photoreactive group. The use of the cyclic olefin compound enables the preparation of a photoreactive polymer having good characteristics such as an alignment characteristic or the like.

In the above-described structure of the cyclic olefin compound, the respective substituents are defined as follows:

The term “alkyl” as used herein refers to a monovalent linear or branched saturated hydrocarbon portion having 1 to 20 carbon atoms, preferably 1 to 10 carbon atoms, more preferably 1 to 6 carbon atoms. The alkyl group inclusively refers to alkyl groups unsubstituted or additionally substituted with a specific substituent, which will be described later. The examples of the alkyl group may comprise methyl, ethyl, propyl, 2-propyl, n-butyl, iso-butyl, tert-butyl, pentyl, hexyl, dodecyl, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, iodomethyl, bromomethyl, etc.

The term “alkenyl” as used herein refers to a monovalent linear or branched hydrocarbon portion having 2 to 20 carbon atoms, preferably 2 to 10 carbon atoms, more preferably 2 to 6 carbon atoms with at least one carbon-carbon double bond. The alkenyl group may form a bonding through carbon atoms including a carbon-carbon double bond or through saturated carbon atoms. The alkenyl group inclusively refers to alkenyl groups unsubstituted or additionally substituted with a specific substituent, which will be described later. The examples of the alkenyl group may comprise ethenyl, 1-propenyl, 2-propenyl, 2-butenyl, 3-butenyl, pentenyl, 5-hexenyl, dodecenyl, etc.

The term “cycloalkyl” as used herein refers to a monovalent saturated or unsaturated mono-, bi- or tri-cyclic non-aromatic hydrocarbon portion having 3 to 12 ring-carbon atoms. The cycloalkyl group inclusively refers to cycloalkyl groups additionally substituted with a specific substituent, which will be described later. The examples of the cycloalkyl group may comprise cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, decahydronaphthalenyl, adamantyl, norbornyl (i.e., bicyclo[2,2,1]hept-5-enyl), etc.

The term “aryl” as used herein refers to a monovalent mono-, bi- or tri-cyclic aromatic hydrocarbon portion having 6 to 40 ring-carbon atoms, preferably 6 to 12 ring-carbon atoms. The aryl group inclusively refers to aryl groups additionally substituted with a specific substituent, which will be described later. The examples of the aryl group may comprise phenyl, naphthalenyl, fluorenyl, etc.

The term “alkoxyaryl” as used herein refers to the above-defined aryl group in which at least one hydrogen atom is substituted by an alkoxy group. The examples of the alkoxyaryl group may comprise methoxyphenyl, ethoxyphenyl, propoxyphenyl, butoxyphenyl, pentoxyphenyl, hextoxyphenyl, heptoxy, octoxy, nanoxy, methoxybiphenyl, methoxynaphthalenyl, methoxyfluorenyl, methoxyanthracenyl, etc.

The term “aralkyl” as used herein refers to the above-defined alkyl group in which at least one hydrogen atom is substituted by an aryl group. The aralkyl group inclusively refers to aralkyl groups additionally substituted with a specific substituent, which will be described later. The examples of the aralkyl may comprise benzyl, benzhydryl, trityl, etc.

The term “alkynyl” as used herein refers to a monovalent linear or branched hydrocarbon portion having 2 to 20 carbon atoms, preferably 2 to 10 carbon atoms, more preferably 2 to 6 carbon atoms with at least one carbon-carbon triple bond. The alkynyl group may form a bonding through carbon atoms including a carbon-carbon triple bond or through saturated carbon atoms. The alkynyl group inclusively refers to alkynyl groups additionally substituted with a specific substituent, which will be described later. The examples of the alkynyl group may comprise ethynyl, propynyl, etc.

The term “alkylene” as used herein refers to a divalent linear or branched saturated hydrocarbon portion having 1 to 20 carbon atoms, preferably 1 to 10 carbon atoms, more preferably 1 to 6 carbon atoms. The alkylene group inclusively refers to alkylene groups additionally substituted with a specific substituent, which will be described later. The examples of the alkylene group may comprise methylene, ethylene, propylene, butylene, hexylene, etc.

The term “alkenylene” as used herein refers to a divalent linear or branched hydrocarbon portion having 2 to 20 carbon atoms, preferably 2 to 10 carbon atoms, more preferably 2 to 6 carbon atoms with at least one carbon-carbon double bond. The alkenylene group may form a bonding through carbon atoms including a carbon-carbon double bond and/or through saturated carbon atoms. The alkenylene group inclusively refers to alkenylene groups additionally substituted with a specific substituent, which will be described later.

The term “cycloalkylene” as used herein refers to a divalent saturated or unsaturated mono-, bi- or tri-cyclic non-aromatic hydrocarbon portion having 3 to 12 ring-carbon atoms. The cycloalkylene group inclusively refers to cycloalkylene groups additionally substituted with a specific substituent, which will be described later. The examples of the cycloalkylene group may comprise cyclopropylene, cyclobutylene, etc.

The term “arylene” as used herein refers to a divalent mono-, bi- or tri-cyclic aromatic hydrocarbon portion having 6 to 20 ring-carbon atoms, preferably 6 to 12 ring-carbon atoms. The arylene group inclusively refers to arylene groups additionally substituted with a specific substituent, which will be described later. The aromatic portion includes carbon atoms only. The examples of the arylene may comprise phenylene, etc.

The term “aralkylene” as used herein refers to a divalent portion of the above-defined alkyl group in which at least one hydrogen atom is substituted by an aryl group. The aralkylene group inclusively refers to aralkylene groups additionally substituted with a specific substituent, which will be described later. The examples of the aralkylene group may comprise benzylene, etc.

The term “alkynylene” as used herein refers to a divalent linear or branched hydrocarbon portion having 2 to 20 carbon atoms, preferably 2 to 10 carbon atoms, more preferably 2 to 6 carbon atoms with at least one carbon-carbon triple bond. The alkynylene group may form a bonding through carbon atoms including a carbon-carbon triple bond or through saturated carbon atoms. The alkynylene group inclusively refers to alkynylene groups additionally substituted with a specific substituent, which will be described later. The examples of the alkynylene group may comprise ethynylene, propynylene, etc.

In the above description, the phrase “a substituent is substituted or unsubstituted” has an inclusive meaning that the substituent is or isn't additionally substituted with the substituent itself or another specific substituent. If not stated otherwise in this specification, the examples of the substituent used as an additional substituent for each substituent may include halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, aryl, haloaryl, aralkyl, haloaralkyl, alkoxy, haloalkoxy, carbonyloxy, halocarbonyloxy, aryloxy, haloaryloxy, silyl, siloxy, or “a polar functional group comprising oxygen, nitrogen, phosphor, sulfur, silicon, or boron” as mentioned above.

The above-described cyclic olefin compound may be prepared by a typical method of introducing a defined substituent, more specifically, a photoreactive group of the formula 1a or 1b on a cyclic olefin such as a norbornene-based compound. The synthesis of the cyclic olefin compound involves, for example, a condensation reaction of norbornene (alkyl)ol, such as norbornene methanol, and a carboxylic compound or the like having a photoreactive group of the formula 1a or 1b. Depending on the structure and the type of the photoreactive group of the formula 1a or 1b, any other different methods can be used to introduce the photoreactive group and prepare the cyclic olefin compound.

On the other hand, the cyclic olefin compound can be used to prepare a photoreactive polymer satisfying the characteristics of the embodiment of the present invention. The photoreactive polymer may comprise, as a main repeating unit, a cyclic olefin-based repeating unit represented by the following formula 3a or 3b:

In the formulas 3a and 3b, independently, m is 50 to 5,000; and q, R1, R2, R3 and R4 are as defined in the formula 1.

This photoreactive polymer, which comprises a repeating unit derived from the cyclic olefin compound, supports the formation of a large free volume between adjacent photoreactive groups owing to the bulky aralkyl structure connected to the ends of the photoreactive groups via a linker L. In the photoreactive polymer, consequently, the photoreactive groups are relatively free to move (flow) or react in the secured large free volume. Hence, the photoreactive polymer can exhibit better excellences in photoreactivity, alignment rate, and photo-alignment, and have good alignment stability so that it undergoes little change in the photo-alignment characteristic in the presence of a change in the exposure conditions once a desired photo-alignment characteristic is acquired.

Accordingly, the photoreactive polymer makes it possible to realize the characteristics of the embodiment of the present invention and exhibits excellences in alignment rate and alignment stability.

The photoreactive polymer may further comprise a norbornene-based repeating unit of the formula 3a or 3b as a main repeating unit. The norbornene-based repeating unit is structurally rigid, and the photoreactive polymer comprising the norbornene-based repeating unit has a relatively high glass transition temperature Tg of about 300° C. or above, preferably about 300 to 350° C., consequently with a higher thermal stability than the existing photoreactive polymers.

The definitions of the respective substituents bonded to the photoreactive polymer are specified above in detail in regard to the cyclic olefin compound of the formula 1 and will not be described any more.

The photoreactive polymer may comprise at least one repeating unit selected from the group consisting of the repeating units of the formula 3a or 3b, or may be a copolymer further comprising another type of repeating unit. The examples of the repeating unit may comprise any olefin-, acrylate- or cyclic-olefin-based repeating unit with or without a bonding to cinnamate-, chalcone- or azo-based photoreactive groups. The exemplary repeating units are disclosed in Korean Patent Laid-open Publication No. 2010-0021751.

To prevent deterioration in good characteristics such as alignment characteristic and alignment rate pertaining to the formula 3a or 3b, the photoreactive polymer may comprise the repeating unit of the formula 3a or 3b in an amount of at least about 50 mol %, more specifically about 50 to 100 mol %, preferably at least about 70 mol %.

The repeating unit of the formula 3a or 3b constituting the photoreactive polymer has a degree of polymerization in the range of about 50 to 5,000, preferably about 100 to 4,000, more preferably about 1,000 to 3,000. The photoreactive polymer has a weight average molecular weight of 10,000 to 1000,000, preferably 20,000 to 500,000. The photoreactive polymer properly included in a coating composition for forming an alignment layer provides the coating composition with good coatability and the alignment layer formed from the coating composition with good liquid crystal alignment.

The photoreactive polymer may be endowed with photoreactivity upon exposure to a polarized radiation having a wavelength of about 150 to 450 nm. For example, the photoreactive polymer can exhibit excellences in photoreactivity, alignment characteristic, alignment rate, alignment stability, or the like upon exposure to a polarized UV radiation having a wavelength of about 200 to 400 nm, more specifically about 250 to 350 nm. More specifically, the photoreactive polymer absorbs a polarized UV radiation in the wavelength range of about 270 to 340 nm to achieve the above-mentioned characteristic value in regard to d(dichloric ratio)/d(mJ/cm²), which guarantees excellences in alignment rate and alignment stability of the photoreactive polymer according to one embodiment of the present invention.

The photoreactive polymer, when comprising a repeating unit of the formula 3a or 3b, may be prepared according to the following preparation methods. One example of the preparation method may comprise conducting an addition polymerization reaction using a monomer represented by the formula 1 in the presence of a catalyst composition comprising a precatalyst containing a transition metal in Group 10, and a cocatalyst to form a repeating unit of the formula 3a:

In the formula 1, q, R1, R2, R3 and R4 are as defined in the formula 3a.

The polymerization reaction may be carried out at a temperature of 10 to 200° C. The polymerization temperature below 10° C. lowers the polymerization activity, while the temperature above 200° C. undesirably causes a cleavage of the catalyst.

The cocatalyst comprises at least one selected from the group consisting of a first cocatalyst providing a Lewis base capable of forming a weak coordinate bond with the metal of the precatalyst; and a second cocatalyst providing a compound comprising a Group 15 electron donor ligand. Preferably, the cocatalyst may be a catalyst mixture comprising the first cocatalyst providing a Lewis base, and optionally the second cocatalyst providing a compound comprising a neutral Group 15 electron donor ligand.

The catalyst mixture may comprise, based on one mole of the precatalyst, 1 to 1,000 moles of the first cocatalyst and 1 to 1,000 moles of the second cocatalyst. The excessively low content of the first or second cocatalyst causes a failure to provide the catalyst activity enough, while an excess of the first or second cocatalyst deteriorates the catalyst activity.

The precatalyst comprising a Group 10 transition metal may be a compound having a Lewis base functional group that is readily leaving from the central transition metal by the first cocatalyst providing a Lewis base and participating in a Lewis acid-base reaction to help the central transition metal change into a catalyst active species. The examples of the precatalyst include allylpalladium chloride dimer ([(Allyl)Pd(Cl)]₂), palladium(II) acetate ((CH₃CO₂)₂Pd), palladium(II) acetylacetonate ([CH₃COCH═C(O—)CH₃]₂Pd), NiBr(NP(CH₃)₃)₄, [PdCl(NB)O(CH₃)]₂, etc.

The first cocatalyst providing a Lewis base capable of forming a weak coordinate bond with the metal of the precatalyst may be a compound that readily reacts with a Lewis base to leave vacancies in the transition metal and forms a weak coordinate bond with a transition metal compound in order to stabilize the resultant transition metal; or a compound providing such a compound. The examples of the first cocatalyst may include borane (e.g., B(C₆F₅)₃), borate (e.g., dimethylanilinium tetrakis(pentafluorophenyl)borate), alkylaluminum (e.g., methylaluminoxane (MAO) or Al(C₂H₅)₃), transition metal halide (e.g., AgSbF₆), etc.

The examples of the second cocatalyst that provides a compound comprising a neutral Group 15 electron donor ligand may include alkyl phosphine, cycloalkyl phosphine, or phenyl phosphine.

The first and second cocatalysts may be used separately, or used together to form a single salt compound used as a compound for activating the catalyst. For example, there may be a compound prepared as an ion pair of alkyl phosphine and a borane or borate compound.

The above-described method may be used to prepare a repeating unit of the formula 3a and a photoreactive polymer according to an embodiment comprising the repeating unit. As for a photoreactive polymer further comprising an olefin-, cyclic-olefin- or acrylate-based repeating unit, typical preparation methods are used for forming each of the corresponding repeating units, which is then copolymerized with the repeating unit of the formula 3a prepared by the above-described method to form the photoreactive polymer.

On the other hand, a photoreactive polymer comprising a repeating unit of the formula 2a may be prepared according to another example of the preparation method. The another exemplary preparation method comprises performing a ring-opening polymerization using a monomer of the formula 1 in the presence of a catalyst composition comprising a precatalyst containing a transition metal in Group 4, 6 or 8, and a cocatalyst to form a repeating unit of the formula 3b. Alternatively, the photoreactive polymer comprising a repeating unit of the formula 3b may be prepared by a method that comprises performing a ring-opening polymerization using norbornene (alkyl)ol, such as norbornene methanol, as a norbornene monomer in the presence of a catalyst composition comprising a precatalyst containing a transition metal in Group 4, 6 or 8, and a cocatalyst to form a ring-opened polymer with a 5-membered ring, and then introducing a photoreactive group on the ring-opened polymer to complete the photoreactive polymer. Here, the introduction of the photoreactive group may be achieved using a condensation reaction of the ring-opened polymer with a carboxylate compound or an acyl chloride compound having a photoreactive group of the formula 1a or 1b.

The ring-opening polymerization step may involve hydrogenation of the double bond of the norbornene ring included in the monomer of the formula 1 to open the norbornene ring, simultaneously beginning a polymerization reaction to prepare a repeating unit of the formula 3b and a photoreactive polymer comprising the repeating unit. Alternatively, polymerization and ring-opening reactions may occur in sequence to form the photoreactive polymer.

The ring-opening polymerization may be carried out in the presence of a catalyst composition, which comprises a precatalyst containing a transition metal in Group 4 (e.g., Ti, Zr, or Hf), Group 6 (e.g., Mo, or W) or Group 8 (e.g., Ru, or Os); a cocatalyst providing a Lewis base capable of forming a weak coordinate bond with the metal of the precatalyst; and optionally a neutral Group 15 or 16 activator for improving the activity of the metal in the precatalyst. In the presence of the catalyst composition, a linear alkene, such as 1-alkene, 2-alkene, etc., controllable in molecular weight is added in an amount of 1 to 100 mol % with respect to the monomer to catalyze a polymerization reaction at 10 to 200° C. Then, a catalyst comprising a transition metal in Group 4 (e.g., Ti, or Zr) or Groups 8 to 10 (e.g., Ru, Ni, or Pd) is added in an amount of 1 to 30 wt. % with respect to the monomer to catalyze a hydrogenation reaction on the double bond of the norbornene ring at 10 to 250° C.

The excessively lower reaction temperature deteriorates the polymerization activity, and the excessively higher reaction temperature results in an undesirable cleavage of the catalyst. The lower hydrogenation temperature deteriorates the reaction activity, while the excessively high hydrogenation temperature causes a cleavage of the catalyst.

The catalyst composition comprises one mole of a precatalyst containing a transition metal in Group 4 (e.g., Ti, Zr, or Hf), Group 6 (e.g., Mo, or W) or Group 8 (e.g., Ru, or Os); 1 to 100,000 moles of a cocatalyst providing a Lewis base capable of forming a weak coordinate bond with the metal of the precatalyst; and optionally 1 to 100 moles of an activator comprising a neutral Group 15 or 16 element for improving the activity of the metal of the precatalyst.

The cocatalyst content less than one mole causes a failure in activation of the catalyst, and the cocatalyst content greater than 100,000 moles deteriorates the catalyst activity. The activator may be unnecessary depending on the type of the precatalyst. The activator content less than one mole ends up with a failure of the catalyst activation, while the activator content greater than 100 moles results in a lower molecular weight.

The hydrogenation reaction fails to occur when the content of the catalyst comprising a transition metal of Group 4 (e.g., Ti, or Zr) or Group 8, 9 or 10 (e.g., Ru, Ni, or Pd) for hydrogenation reaction is less than 1 wt. % with respect to the monomer. The catalyst content greater than 30 wt. % undesirably results in a discoloration of the polymer.

The precatalyst comprising a transition metal in Group 4 (e.g., Ti, Zr, or Hf), Group 6 (e.g., Mo, or W) or Group 8 (e.g., Ru, or Os) may refer to a transition metal compound, such as TiCl₄, WCl₆, MoCl₅, RuCl₃, or ZrCl₄, having a functional group that is readily leaving from the central transition metal by the first cocatalyst providing a Lewis base and participating in a Lewis acid-base reaction to help the central transition metal change into a catalyst active species.

The examples of the cocatalyst providing a Lewis base capable of forming a weak coordinate bond with the metal of the precatalyst may include borane, such as B((C₆F₅)₃, or borate; or alkylaluminum, alkylaluminum halide or aluminum halide, such as methylaluminoxane (MAO), Al(C₂H₅)₃, or Al(CH₃)Cl₂. Here, aluminum may be replaced by a substituent, such as lithium, magnesium, germanium, lead, zinc, tin, silicon, etc. Hence, the cocatalyst is a compound that readily reacts with a Lewis base to provide vacancies in the transition metal and forms a weak coordinate bond with the transition metal compound in order to stabilize the produced transition metal; or a compound providing such a compound.

Depending on the type of the precatalyst, a polymerization activator is required or not. The examples of the activator comprising a neutral element in Group 15 or 16 may include water, methanol, ethanol, isopropyl alcohol, benzylalcohol, phenol, ethyl mercaptan, 2-chloroethanol, trimethylamine, triethylamine, pyridine, ethylene oxide, benzoyl peroxide, t-butyl peroxide, or the like.

The catalyst comprising a transition metal in Group 4 (e.g., Ti, or Zr) or Group 8, 9 or 10 (e.g., Ru, Ni, or Pd) used for hydrogenation reaction may be prepared as a homogeneous form miscible with a solvent, or as a metal complex catalyst impregnated on a particulate support. Preferably, the examples of the particulate support include silica, titania, silica/chromia, silica/chromia/titania, silica/alumina, aluminum phosphate gel, silanized silica, silica hydrogel, montmorillonite clay, or zeolite.

The above-described method is used to prepare the repeating unit of the formula 3b and the photoreactive polymer of the embodiment comprising the repeating unit. As for the photoreactive polymer that further comprises an olefin-, cyclic-olefin- or acrylate-based repeating unit, the respective repeating units are first formed through the corresponding preparation methods and then copolymerized with a repeating unit of the formula 3b prepared by the above-described method to form the photoreactive polymer.

In accordance with still another embodiment of the invention, there is provided an alignment layer comprising the above-described photoreactive polymer. The alignment layer may be of a thin film form or an alignment layer form.

The alignment layer may be prepared using known preparation methods with constituent components known to those skilled in the art, excepting that a photo-aligned polymer is used as the photoreactive polymer.

For example, the alignment layer is prepared by mixing the photoreactive polymer with a binder resin and a photo-initiator, dissolving the mixture in an organic solvent to obtain a coating composition, applying the coating composition on a base, and then curing the coating composition by UV exposure.

Here, the binder resin may be an acrylate-based resin, more specifically, pentaerythritol triarylate, dipentaerythritol hexaacrylate, trimethylolpropane triacrylate, tris(2-acryloyloxyethyl) isocyanurate, etc.

The photo-initiator may be any typical photo-initiator known to be applicable to alignment layers without any limitations, such as, for example, Irgacure 907 or Irgacure 819.

The examples of the organic solvent may include toluene, anisole, chlorobenzene, dichloroethane, cyclohexane, cyclopentane, propylene glycol, methyl ether, acetate, etc. Other organic solvent may also be used without any limitations, because the photoreactive norbornene-based copolymer has a good solubility in various organic solvents.

In the coating composition, the content of the solid components comprising the binder resin and the photo-initiator may be in the range of 1 to 15 wt. %, preferably 10 to 15 wt. % to cast the alignment layer into films, or 1 to 5 wt. % to cast the alignment layer into thin films.

The alignment layer may be formed, for example, on a support as shown in FIG. 1, or under liquid crystals to achieve liquid crystal alignment. Here, the base may be a cyclic polymer base, an acryl polymer base, or a cellulose polymer base. The coating composition is applied on the base by different methods, such as bar coating, spin coating, blade coating, etc. and then cured under UV exposure to form an alignment layer.

The UV curing causes photo-alignment, in which step a polarized UV radiation having a wavelength of about 150 to 450 nm is applied to bring about alignment. Here, the exposure intensity of the radiation is about 10 mJ/cm² to 10 J/cm², preferably, about 20 mJ/cm² to 2.5 J/c m².

The UV radiation as used herein may be any UV radiations polarized by passing through or being reflected from (a) a polarizer using a dielectric anisotropic coating on the surface of a transparent substrate such as quartz glass, soda-lime glass, soda-lime-free glass, or the like; (b) a polarizer with fine aluminum or other metallic wires; or (c) a Brewster polarizer using reflection from quartz glass.

The substrate temperature during UV exposure is preferably the room temperature. Under circumstances, the substrate may be heated at 100° C. or below during UV exposure. Preferably, the final layer thus obtained from the above-described steps has a thickness of about 30 to 1,000 μm.

The above-described method is adopted to form an alignment layer. The use of the photoreactive polymer in the alignment layer enables the alignment layer to have good interactions with liquid crystal molecules, achieving effective photo-alignment. Also, the photoreactive polymer provides the alignment layer with desired alignment characteristics uniform and stable and enables a preparation of the alignment layer with more efficiency due to its high alignment rate.

In accordance with still further another embodiment of the invention, there is provided a display device comprising the alignment layer. The display device may be a liquid crystal display device comprising the alignment layer for liquid crystal alignment; or a stereoscopic imaging display device included in optical films or filters to create stereoscopic images. The constituent components of the display device are the same as those of a typical display device, excepting that the photoreactive polymer and the alignment layer are included, and will not be described any more in further detail.

In the following are set forth preferred examples of the invention for better understanding of the invention. It is to be understood that the examples are only for illustrative purposes and are not intended to limit the scope of the invention.

Comparative Example 1 Polyvinyl Cinnamate

Polyvinyl cinnamate was purchased from Aldrich Chemicals.

Comparative Example 2 Poly(cinnamate-ethyl-methacrylate)

Hydroxyl ethyl methacrylate (10 g), cinnamoyl chloride (1 eq), and triethylamine (3 eq) were dissolved in THF and stirred at 10° C. for 16 hours. After completion of the reaction, the reaction mixture was filtered to eliminate salts and extracted with EA/H₂O. Removed of the organic solvent, the residual was purified by column chromatography (EA/hexane (2/1)) to obtain a product (yield: 82%).

The product (5 g) and AlBN (0.02 eq) were put in toluene and stirred at 70° C. for 15 hours. Then, the polymerization solution was added to ethanol to precipitate a polymer product (Mw=46 k, PDI=2.38, yield=62%).

Example 1 Preparation of 4-benzyloxy-cinnamate-5-norbornene(cyclic olefin compound)

4-Benzyloy-benzaldehyde (10 g, 47 mmol), malonic acid (2 eq.) and piperidine (0.1 eq.) were dissolved in pyridine (5 eq.) and stirred at 80° C. for 5 hours. After completion of the reaction, the reaction mixture was cooled down to the room temperature and neutralized with 3M HCl. The white solid thus obtained was filtered out and dried in a vacuum oven to yield 4-benzyloxy-cinnamic acid.

The 4-benzyloxy-cinnamic acid (5 g, 19.7 mmol), norbornene-5-ol (19 mmol) and Zr(AcAc) (0.2 mol. %) were put in xylene and stirred at 190° C. for 24 hours. Then, the reaction mixture was washed with 1M HCl and 1M NaHCO3 aqueous solutions and removed of the solvent to obtain a yellowish solid, 4-benzyloxy-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.87 (1, m) 2.56 (1, m) 2.93 (1, s) 5.11 (2, s) 5.98˜6.19 (2, m) 6.36 (1, d) 7.3˜7.5 (9, m) 7.63 (2, d).

Example 2 Preparation of 4-benzyloxy-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-benzyloxy-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.87 (1, m) 2.47 (1, m) 2.93 (1, s) 3.8˜4.25 (2, m) 5.11 (2, s) 5.98˜6.19 (2, m) 6.36 (1, d) 7.3˜7.5 (9, m) 7.63 (2, d).

Example 3 Preparation of 4-benzyloxy-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-benzyloxy-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.33˜1.6 (3, m) 1.8 (1, m) 2.43 (1, m) 2.90 (1, s) 3.3˜3.9 (2, m) 5.11 (2, s) 5.95˜6.17 (2, m) 6.36 (1, d) 7.3˜7.5 (9, m) 7.63 (2, d).

Example 4 Preparation of 4-(4-fluoro-benzyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-fluoro-benzyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-fluoro-benzyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.67 (1, m) 2.93 (1, s) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.1 (2, m) 7.4 (2, m) 7.49 (2, d) 7.65 (1, s).

Example 5 Preparation of 4-(4-fluoro-benzyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 4, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-fluoro-benzyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.47 (1, m) 2.93 (1, s) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.1 (2, m) 7.4 (2, m) 7.49 (2, d) 7.65 (1, s).

Example 6 Preparation of 4-(4-fluoro-benzyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 4, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-fluoro-benzyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.36˜1.6 (3, m) 1.86 (1, m) 2.45 (1, m) 2.91 (1, s) 3.32˜3.96 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.1 (2, m) 7.4 (2, m) 7.49 (2, d) 7.65 (1, s).

Example 7 Preparation of 4-(4-methyl-benzyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-methyl-benzyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-methyl-benzyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.21˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.37 (3, s) 2.67 (1, m) 2.93 (1, s) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2, m) 7.1 (2, m) 7.4 (2, m) 7.45 (2, d) 7.65 (1, s).

Example 8 Preparation of 4-(4-methyl-benzyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 7, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-methyl-benzyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.37 (3, s) 2.47 (1, m) 2.93 (1, s) 3.74˜4.28 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2, d) 7.1 (2, m) 7.4 (2, m) 7.47 (2, d) 7.65 (1, s).

Example 9 Preparation of 4-(4-methyl-benzyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 7, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-methyl-benzyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.35˜1.6 (3, m) 1.86 (1, m) 2.37 (3, s) 2.45 (1, m) 2.91 (1, s) 3.33˜3.96 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2, d) 7.1 (2, m) 7.4 (2, m) 7.49 (2, d) 7.65 (1, s).

Example 10 Preparation of 4-(4-methoxy-benzyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-methoxy-benzyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-methoxy-benzyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.20˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.67 (1, m) 2.93 (1, s) 4.44 (3, s) 5.05 (2, s) 5.98˜6.11 (2, m) 6.30 (1, d) 7.01 (2, d) 7.16 (2, m) 7.44 (2, m) 7.51 (2, d) 7.65 (1, s).

Example 11 Preparation of 4-(4-methoxy-benzyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 10, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-methoxy-benzyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.47 (1, m) 2.93 (1, s) 3.75˜4.3 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2, d) 7.01 (2, d) 7.16 (2, m) 7.44 (2, m) 7.51 (2, d) 7.65 (1, s).

Example 12 Preparation of 4-(4-methoxy-benzyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 10, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-methoxy-benzyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.33˜1.57 (3, m) 1.86 (1, m) 2.45 (1, m) 2.92 (1, s) 3.32˜3.96 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 7.01 (2, d) 7.16 (2, m) 7.44 (2, m) 7.51 (2, d) 7.65 (1, s).

Example 13 Preparation of 4-(2-naphthalene-methyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(2-naphthalene-methyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(2-naphthalene-methyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.64 (1, m) 2.93 (1, s) 5.28 (2, s) 5.97˜6.11 (2, m) 6.31 (1, d) 6.63 (2, d) 7.5 (6, m) 7.9 (4, m).

Example 14 Preparation of 4-(2-naphthalene-methyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 13, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(2-naphthalene-methyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.48 (1, m) 2.91 (1, s) 3.75˜4.3 (2, m) 5.28 (2, s) 5.97˜6.11 (2, m) 6.31 (1, d) 6.63 (2, d) 7.5 (6, m) 7.9 (4, m).

Example 15 Preparation of 4-(2-naphthalene-methyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 13, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(2-naphthalene-methyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.21˜1.27 (2, m) 1.37˜1.6 (3, m) 1.86 (1, m) 2.45 (1, m) 2.90 (1, s) 3.62˜4.05 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.31 (1, d) 6.63 (2, d) 7.5 (6, m) 7.9 (4, m).

Example 16 Preparation of 4-(4-methylketone benzyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-methylketone benzyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-methyl ketone benzyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.67 (1, m) 2.93 (1, s) 3.66 (3, s) 5.05 (2, s) 5.97˜6.11 (2, m) 6.27 (1, d) 7.0 (2, d) 7.1 (2, m) 7.4 (2, m) 7.50 (2, d) 7.65 (1, s).

Example 17 Preparation of 4-(4-methylketone benzyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 16, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-methylketone benzyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.87 (1, m) 2.47 (1, m) 2.93 (1, s) 3.66 (3, s) 3.8˜4.25 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.27 (1, d) 7.0 (2, d) 7.1 (2, m) 7.4 (2, m) 7.50 (2, d) 7.65 (1, s).

Example 18 Preparation of 4-(4-methylketone benzyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 16, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-methylketone benzyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.24˜1.29 (2, m) 1.33˜1.6 (3, m) 1.8 (1, m) 2.43 (1, m) 2.90 (1, s) 3.66 (3, s) 3.8˜4.25 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.27 (1, d) 7.0 (2, d) 7.1 (2, m) 7.4 (2, m) 7.50 (2, d) 7.65 (1, s).

Example 19 Preparation of 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(1-phenyl perfluoroheptyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.87 (1, m) 2.56 (1, m) 2.93 (1, s) 5.10 (2, s) 5.96˜6.16 (2, m) 6.55 (1, d) 7.4˜7.55 (5, m) 7.65 (2, d) 7.68 (4, m).

Example 20 Preparation of 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 19, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.87 (1, m) 2.56 (1, m) 2.93 (1, s) 3.75˜4.3 (2, m) 5.10 (2, s) 5.96˜6.16 (2, m) 6.55 (1, d) 7.4˜7.55 (5, m) 7.65 (2, d) 7.68 (4, m).

Example 21 Preparation of 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 19, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.34˜1.59 (3, m) 1.86 (1, m) 2.56 (1, m) 2.92 (1, s) 3.31˜3.96 (2, m) 5.10 (2, s) 5.96˜6.16 (2, m) 6.55 (1, d) 7.4˜7.55 (5, m) 7.65 (2, d) 7.68 (4, m).

Example 22 Preparation of 4-(4-benzyloxy)-benzyloxy-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-benzyloxy)-benzyloxy-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-benzyloxy)-benzyloxy-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.67 (1, m) 2.93 (1, s) 5.16 (4, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.99˜7.15 (8,d) 7.4˜7.51 (5, d) 7.61 (1, s).

Example 23 Preparation of 4-(4-benzyloxy)-benzyloxy-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 22, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-benzyloxy)-benzyloxy-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.47 (1, m) 2.93 (1, s) 3.75˜4.3 (2, m) 5.16 (4, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.99˜7.15 (8,d) 7.4˜7.51 (5, d) 7.61 (1, s).

Example 24 Preparation of 4-(4-benzyloxy)-benzyloxy-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 22, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-benzyloxy)-benzyloxy-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.36˜1.6 (3, m) 1.86 (1, m) 2.45 (1, m) 2.91 (1, s) 3.32˜3.96 (2, m) 5.16 (4, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.99˜7.15 (8,d) 7.4˜7.51 (5, d) 7.61 (1, s).

Example 25 Preparation of 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.55 (1, m) 2.91 (1, s) 5.08 (4, s) 5.91˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.20 (2, m) 7.31˜7.63 (8, m) 7.68 (1, s) 7.84 (2, d).

Example 26 Preparation of 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 25, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.55 (1, m) 2.92 (1, s) 3.75˜4.3 (2, m) 5.08 (4, s) 5.91˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.20 (2, m) 7.31˜7.63 (8, m) 7.68 (1, s) 7.84 (2, d).

Example 27 Preparation of 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 25, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.36˜1.6 (3, m) 1.86 (1, m) 2.55 (1, m) 2.92 (1, s) 3.32˜3.96 (2, m) 5.08 (4, s) 5.91˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.20 (2, m) 7.31˜7.63 (8, m) 7.68 (1, s) 7.84 (2, d).

Example 28 Preparation of 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-trifluoromethyl)-benzyloxy-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.67 (1, m) 2.93 (1, s) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 7.11˜7.25 (4, m) 7.4 (2, m) 7.60˜7.68 (3, m).

Example 29 Preparation of 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 28, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.47 (1, m) 2.93 (1, s) 3.74˜4.28 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 7.11˜7.25 (4, m) 7.4 (2, m) 7.60˜7.68 (3, m).

Example 30 Preparation of 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 28, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.36˜1.6 (3, m) 1.86 (1, m) 2.45 (1, m) 2.91 (1, s) 3.32˜3.96 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 7.11˜7.25 (4, m) 7.4 (2, m) 7.60˜7.68 (3, m).

Example 31 Preparation of 4-(4-bromo-benzyloxy)-cinnamate-5-norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 1, excepting that 4-(4-bromo-benzyloxy)-benzaldehyde was used instead of 4-benzyloxy-benzaldehyde to prepare 4-(4-bromo-benzyloxy)-cinnamate-5-norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.67 (1, m) 2.93 (1, s) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.1 (2, m) 7.30 (2, m) 7.45 (2, d) 7.61 (1, s).

Example 32 Preparation of 4-(4-bromo-benzyloxy)-cinnamate-5-methyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 31, excepting that norbornene-5-methanol was used instead of norbornene-5-ol to prepare 4-(4-bromo-benzyloxy)-cinnamate-5-methyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.47 (1,d) 1.88 (1, m) 2.47 (1, m) 2.93 (1, s) 3.75˜4.3 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.1 (2, m) 7.30 (2, m) 7.45 (2, d) 7.61 (1, s).

Example 33 Preparation of 4-(4-bromo-benzyloxy)-cinnamate-5-ethyl norbornene(cyclic olefin compound)

The procedures were performed in the same manner as described in Example 31, excepting that norbornene-5-ethanol was used instead of norbornene-5-ol to prepare 4-(4-bromo-benzyloxy)-cinnamate-5-ethyl norbornene.

NMR(CDCl₃ (500 MHz), ppm): 0.6 (1, m) 1.22˜1.27 (2, m) 1.36˜1.6 (3, m) 1.86 (1, m) 2.45 (1, m) 2.91 (1, s) 3.32˜3.96 (2, m) 5.05 (2, s) 5.97˜6.11 (2, m) 6.30 (1, d) 6.97 (2,d) 7.1 (2, m) 7.30 (2, m) 7.45 (2, d) 7.61 (1, s).

Example 34 Polymerization of 4-benzyloxy-cinnamate-5-norbornene

In a 250 ml Schlenk flask were placed 4-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 1 as a monomer, and purified toluene (400 wt. %) as a solvent. 1-octene (10 mol. %) was also added. Under agitation, the mixture was heated to 90° C. To the flask were added Pd(OAc)₂ (16 μmol) and tricyclohexylphosphine (32 μmol) in 1 ml of dichloromethane as a catalyst, and dimethylanilinium tetrakiss(pentafluorophenyl)borate (32 μmol) as a cocatalyst. The mixture was stirred at 90° C. for 16 hours to bring about a reaction.

After completion of the reaction, the reactant mixture was put in an excess of ethanol to obtain a white polymer precipitate. The precipitate was filtered out through a glass funnel to collect a polymer, which was then dried in a vacuum oven at 60° C. for 24 hours to yield a final polymer product (Mw=198 k, PDI=3.22, yield=68%).

Example 35 Polymerization of 4-benzyloxy-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 2 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=162 k, PDI=3.16, yield=81%).

Example 36 Polymerization of 4-benzyloxy-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 3 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=159 k, PDI=4.10, yield=80%).

Example 37 Polymerization of 4-(4-fluoro-benzyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-fluoro-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 4 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=121 k, PDI=3.52, yield=62%).

Example 38 Polymerization of 4-(4-fluoro-benzyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-fluoro-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 5 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=135 k, PDI=2.94, yield=82%).

Example 39 Polymerization of 4-(4-fluoro-benzyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-fluoro-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 6 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=144 k, PDI=4.03, yield=74%).

Example 40 Polymerization of 4-(4-methyl-benzyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methyl-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 7 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=111 k, PDI=3.56, yield=58%).

Example 41 Polymerization of 4-(4-methyl-benzyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methyl-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 8 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=134 k, PDI=3.71, yield=75%).

Example 42 Polymerization of 4-(4-methyl-benzyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methyl-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 9 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=130 k, PDI=4.00, yield=71%).

Example 43 Polymerization of 4-(4-methoxy-benzyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methoxy-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 10 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=146 k, PDI=3.42, yield=74%).

Example 44 Polymerization of 4-(4-methoxy-benzyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methoxy-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 11 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=144 k, PDI=3.04, yield=79%).

Example 45 Polymerization of 4-(4-methoxy-benzyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methoxy-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 12 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=123 k, PDI=3.69, yield=71%).

Example 46 Polymerization of 4-(2-naphthalene-methyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(2-naphthalene-methyloxy)-cinnamate-5-norbornene (50 mmol) of Example 13 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=91 k, PDI=4.01, yield=54%).

Example 47 Polymerization of 4-(2-naphthalene-methyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(2-naphthalene-methyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 14 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=83 k, PDI=3.97, yield=61%).

Example 48 Polymerization of 4-(2-naphthalene-methyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(2-naphthalene-methyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 15 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=102 k, PDI=3.72, yield=43%).

Example 49 Polymerization of 4-(4-methyl ketone benzyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methylketone benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 16 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=109 k, PDI=4.23, yield=47%).

Example 50 Polymerization of 4-(4-methylketone benzyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methylketone benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 17 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=111 k, PDI=4.21, yield=51%).

Example 51 Polymerization of 4-(4-methylketone benzyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-methylketone benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 18 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=87 k, PDI=3.32, yield=43%).

Example 52 Polymerization of 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-norbornene (50 mmol) of Example 19 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=116 k, PDI=3.09, yield=57%).

Example 53 Polymerization of 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 20 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=105 k, PDI=3.88, yield=69%).

Example 54 Polymerization of 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 21 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=87 k, PDI=4.62, yield=51%).

Example 55 Polymerization of 4-(4-benzyloxy)-benzyloxy-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-benzyloxy)-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 22 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=137 k, PDI=3.19, yield=68%).

Example 56 Polymerization of 4-(4-benzyloxy)-benzyloxy-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-benzyloxy)-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 23 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=121 k, PDI=3.52, yield=74%).

Example 57 Polymerization of 4-(4-benzyloxy)-benzyloxy-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-benzyloxy)-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 24 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=130 k, PDI=4.67, yield=63%).

Example 58 Polymerization of 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 25 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=154 k, PDI=3.22, yield=72%).

Example 59 Polymerization of 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 26 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=148 k, PDI=3.61, yield=73%).

Example 60 Polymerization of 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 27 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=116 k, PDI=4.17, yield=68%).

Example 61 Polymerization of 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 28 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=133 k, PDI=3.10, yield=44%).

Example 62 Polymerization of 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 29 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=121 k, PDI=3.38, yield=48%).

Example 63 Polymerization of 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 30 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=127 k, PDI=3.32, yield=41%).

Example 64 Polymerization of 4-(4-bromo-benzyloxy)-cinnamate-5-norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-bromo-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 31 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=168 k, PDI=3.06, yield=74%).

Example 65 Polymerization of 4-(4-bromo-benzyloxy)-cinnamate-5-methyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-bromo-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 32 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=160 k, PDI=3.24, yield=83%).

Example 66 Polymerization of 4-(4-bromo-benzyloxy)-cinnamate-5-ethyl norbornene

The procedures were performed in the same manner as described in Example 34, excepting that 4-(4-bromo-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 33 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to obtain a polymer product (Mw=146 k, PDI=3.52, yield=72%).

Example 67 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-Benzyloxy-Cinnamate-5-Norbornene

In a 250 ml Schlenk flask in the Ar atmosphere were placed 4-benzyloxy-cinnamate-5-norbornene (50 mmol) and then purified toluene (600 wt. %) as a solvent. With the flask maintained at a polymerization temperature of 80° C., triethyl aluminum (1 mmol) was added as a cocatalyst. Subsequently, to the flask was added 1 ml (WCl₆: 0.01 mmol, ethanol: 0.03 mmol) of a 0.01M (mol/L) toluene solution containing a mixture of tungsten hexachloride (WCl₆) and ethanol at a mixing ratio of 1:3. Finally, 1-octene (15 mol.%) was added as a molecular weight modifier to the flask, which was then stirred at 80° C. for 18 hours to bring about a reaction. After completion of the reaction, a small amount of ethyl vinyl ether as a polymerization inhibitor was added dropwise to the polymerization solution, and the flask was stirred for 5 minutes.

With the polymerization solution transferred to a 300 mL high-pressure reactor, 0.06 ml of triethyl aluminum (TEA) was added to the solution. Subsequently, 0.50 g of grace raney nickel (slurry phase in water) was added, and the solution was stirred at 150° C. for 2 hours under the hydrogen pressure maintained at 80 atm to bring about a reaction. After completion of the reaction, the polymerization solution was added dropwise to acetone to cause precipitation. The precipitate thus obtained was filtered out and dried in a vacuum oven at 70° C. for 15 hours, thereby obtaining a ring-opened hydrogenated polymer of 4-benzyloxy-cinnamate-5-norbornene (Mw=83 k, PDI=4.92, yield=88%).

Example 68 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-Benzyloxy-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 2 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=87 k, PDI=4.22, yield=87%).

Example 69 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-Benzyloxy-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 3 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=71 k, PDI=4.18, yield=80%).

Example 70 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Fluoro-Benzyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-fluoro-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 4 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=90 k, PDI=3.40, yield=71%).

Example 71 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Fluoro-Benzyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-fluoro-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 5 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=87 k, PDI=3.98, yield=76%).

Example 72 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Fluoro-Benzyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-fluoro-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 6 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=68 k, PDI=3.51, yield=74%).

Example 73 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methyl-Benzyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methyl-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 7 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=69 k, PDI=4.13, yield=77%).

Example 74 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methyl-Benzyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methyl-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 8 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=81 k, PDI=3.49, yield=84%).

Example 75 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methyl-Benzyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methyl-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 9 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=55 k, PDI=5.37, yield=68%).

Example 76 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methoxy-Benzyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methoxy-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 10 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=88 k, PDI=3.56, yield=84%).

Example 77 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methoxy-Benzyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methoxy-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 11 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=81 k, PDI=3.14, yield=80%).

Example 78 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methoxy-Benzyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methoxy-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 12 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=84 k, PDI=3.90, yield=73%).

Example 79 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(2-Naphthalene-Methyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(2-naphthalene-methyloxy)-cinnamate-5-norbornene (50 mmol) of Example 13 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=49 k, PDI=4.53, yield=55%).

Example 80 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(2-Naphthalene-Methyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(2-naphthalene-methyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 14 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=53 k, PDI=3.91, yield=51%).

Example 81 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(2-Naphthalene-Methyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(2-naphthalene-methyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 15 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=59 k, PDI=3.99, yield=54%).

Example 82 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methylketone Benzyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methylketone benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 16 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=93 k, PDI=3.49, yield=88%).

Example 83 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methylketone Benzyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methylketone benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 17 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=85 k, PDI=4.26, yield=81%).

Example 84 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Methylketone Benzyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-methylketone benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 18 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=94 k, PDI=4.56, yield=71%).

Example 85 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(1-Phenyl Perfluoroheptyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-norbornene (50 mmol) of Example 19 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=42 k, PDI=4.37, yield=54%).

Example 86 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(1-Phenyl Perfluoroheptyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 20 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=45 k, PDI=3.92, yield=52%).

Example 87 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(1-Phenyl Perfluoroheptyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(1-phenyl perfluoroheptyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 21 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=44 k, PDI=4.52, yield=43%).

Example 88 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Benzyloxy)-Benzyloxy-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-benzyloxy)-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 22 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=82 k, PDI=3.44, yield=70%).

Example 89 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Benzyloxy)-Benzyloxy-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-benzyloxy)-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 23 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=76 k, PDI=3.67, yield=73%).

Example 90 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Benzyloxy)-Benzyloxy-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-benzyloxy)-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 24 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=68 k, PDI=4.81, yield=65%).

Example 91 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Fluoro-Phenyloxy)-Benzyloxy-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 25 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=51 k, PDI=4.72, yield=41%).

Example 92 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Fluoro-Phenyloxy)-Benzyloxy-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 26 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=55 k, PDI=4.13, yield=47%).

Example 93 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Fluoro-Phenyloxy)-Benzyloxy-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-fluoro-phenyloxy)-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 27 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=49 k, PDI=4.11, yield=42%).

Example 94 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Trifluoromethyl)-Benzyloxy-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-norbornene (50 mmol) of Example 28 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=53 k, PDI=3.01, yield=56%).

Example 95 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Trifluoromethyl)-Benzyloxy-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-methyl norbornene (50 mmol) of Example 29 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=72 k, PDI=3.95, yield=55%).

Example 96 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Trifluoromethyl)-Benzyloxy-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-trifluoromethyl)-benzyloxy-cinnamate-5-ethyl norbornene (50 mmol) of Example 30 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=59 k, PDI=3.72, yield=50%).

Example 97 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Bromo-Benzyloxy)-Cinnamate-5-Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-bromo-benzyloxy)-cinnamate-5-norbornene (50 mmol) of Example 31 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=97 k, PDI=3.14, yield=80%).

Example 98 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Bromo-Benzyloxy)-Cinnamate-5-Methyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-bromo-benzyloxy)-cinnamate-5-methyl norbornene (50 mmol) of Example 32 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=93 k, PDI=3.28, yield=83%).

Example 99 Polymer Preparation Using Ring-Opening Methathesis Polymerization and Hydrogenation of 4-(4-Bromo-Benzyloxy)-Cinnamate-5-Ethyl Norbornene

The procedures were performed in the same manner as described in Example 67, excepting that 4-(4-bromo-benzyloxy)-cinnamate-5-ethyl norbornene (50 mmol) of Example 33 was used as a monomer instead of 4-benzyloxy-cinnamate-5-norbornene of Example 1 to form a polymer (Mw=88 k, PDI=3.93, yield=81%).

Experimental Example 1 Fabrication of Liquid Crystal Film and Evaluation of Alignment Characteristics

Based on the total weight of the solution, 2 to 3 wt. % of each photoreactive polymer of Examples and Comparative Examples, 0.5 to 1.0 wt. % of a binder (i.e., an acryl-based binder, such as PETA, DPHA or triacryl isocyanurate), and 0.05 to 1 wt. % of a photo-initiator (Irgacure 907, Ciba) were dissolved in a toluene solvent, and the resultant solution was put dropwise on a glass substrate or a polymer film (e.g., COC, COP, or TAC) to conduct a bar coating. The bar-coated film was dried at 80° C. for 2 min. and exposed to a polarized UV radiation to form an alignment layer through photo-alignment. A-plate liquid crystal (25 wt. % in toluene) was put dropwise on the alignment layer for bar coating, dried at 60° C. for 2 min. and exposed to 20 mJ of UV radiation for liquid crystal curing.

The respective alignment layers prepared from the photoreactive polymers of Examples 34, 38 and 50, and Comparative Examples 1 and 2 were measured in regard to a change of d(dichloric ratio)/d(mJ/cm²) as follows.

The photoreactive polymers were exposed to a polarized UV radiation having a wavelength of about 150 to 450 nm so that the exposure dose on the photoreactive polymer was 20 mJ/cm² per second. The exposure time was adjusted to control the total exposure dose on the polymer in the alignment layer. The dichloric ratio based on the exposure time and the total exposure dose was then measured. For measurement of the dichloric ratio, polarizers were arranged in a UV-vis spectrometer to determine absorbance A(parallel) and absorbance A(perpendicular) and calculate the dichloric ratio according to an equation given by DR=(A(∥)−A(⊥))/(A(∥)+A(⊥)), where the reference wavelength was 310 nm. From the dichloric ratio measured by the total exposure dose, a variation in the dichloric ratio per unit exposure dose as given by d(dichloric ratio)/d(mJ/cm²) was calculated according to the total exposure dose. The results are presented in FIGS. 2 and 3.

More specifically, the change of d(dichloric ratio)/d(mJ/cm²) that is a variation in the dichloric ratio per unit exposure dose (mJ/cm²) was measured based on the total exposure dose 250 mJ/cm² or less and plotted in a graph as shown in FIG. 2. While the exposure time and the exposure dose were increased, the change of a variation in the dichloric ratio per unit exposure dose (mJ/cm²) as given by d(dichloric ratio)/d(mJ/cm²) was measured based on the total exposure dose of 500 mJ/cm² or more after the start of exposure and plotted in a graph as shown in FIG. 3.

Referring to FIG. 2, the photoreactive polymers according to the examples had such an abrupt change in the dichloric ratio at the early stage of the exposure that the maximum absolute value of d(dichloric ratio)/d(mJ/cm²), a variation in the dichloric ratio per unit exposure dose (mJ/cm²), amounted to at least about 0.003 (e.g., about 0.0035 for Example 38, about 0.0059 for Example 59, or about 0.007 for Example 34) when the total exposure dose reached about 20 mJ/cm² immediately after the start of exposure. Referring to FIG. 3, there was little change in the dichloric ratio that the absolute value of a variation in the dichloric ratio per unit exposure dose as given by d(dichloric ratio)/d(mJ/cm²) was maintained in the range of about 0 to 0.00006, for example, about 0 to 0.00002 even with a consistent increase in the exposure time and the total exposure dose once the total exposure dose reached a defined level.

Accordingly, the photoreactive polymers of the above examples had a very high alignment rate in the early stage of the exposure and showed good alignment stability that there was little change in the alignment rate once a desired alignment characteristic was acquired. In contrast, the photoreactive polymers of the comparative examples did not have such a characteristic. 

What is claimed is:
 1. A photoreactive polymer comprising a cyclic olefin-based repeating unit with at least one photoreactive substituent, the photoreactive polymer being at least 0.003 in the maximum absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to a polarized UV radiation having a wavelength of 150 to 450 nm at a total exposure dose of 20 mJ/cm² or less, wherein the photoreactive substituent has a photoreactive radical represented by the following Formula 1a or 1b,

wherein A is chemical bond, oxygen, sulfur, or —NH—; B is selected from the group consisting of chemical bond, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, carbonyl, carboxy, ester, substituted or unsubstituted arylene having 6 to 40 carbon atoms, and substituted or unsubstituted heteroarylene having 6 to 40 carbon atoms; X is oxygen or sulfur; R9 is selected from the group consisting of chemical bond, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, substituted or unsubstituted alkenylene having 2 to 20 carbon atoms, substituted or unsubstituted cycloalkylene having 3 to 12 carbon atoms, substituted or unsubstituted arylene having 6 to 40 carbon atoms, substituted or unsubstituted aralkylene having 7 to 15 carbon atoms, and substituted or unsubstituted alkynylene having 2 to 20 carbon atoms; at least one of R10 to R14 is a radical represented by -L-R15-R16- (substituted or unsubstituted C6-C40 aryl), among the R10 to R14, the remainders other than the radical of -L-R15-R16- (substituted or unsubstituted C6-C40 aryl) are the same as or different from one another and independently selected from the group consisting of hydrogen; halogen; substituted or unsubstituted alkyl having 1 to 20 carbon atoms; substituted or unsubstituted alkoxy having 1 to 20 carbon atoms; substituted or unsubstituted aryloxy having 6 to 30 carbon atoms; substituted or unsubstituted aryl having 6 to 40 carbon atoms; and heteroaryl having 6 to 40 carbon atoms with a hetero element in Group 14, 15, or 16; L is selected from the group consisting of oxygen, sulfur, —NH—, substituted or unsubstituted alkylene having 1 to 20 carbon atoms, carbonyl, carboxy, —CONH—, and substituted or unsubstituted arylene having 6 to 40 carbon atoms; R15 is substituted or unsubstituted alkyl having 1 to 10 carbon atoms; and R16 is selected from the group consisting of chemical bond, —O—, —C(═O)O—, —OC(═O)—, —NH—, —S—, and —C(═O)—.
 2. The photoreactive polymer as claimed in claim 1, wherein the maximum absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) is 0.003 to 0.008.
 3. The photoreactive polymer as claimed in claim 1, wherein the maximum absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to a polarized UV radiation having a wavelength of 150 to 450 nm at a total exposure dose of 20 mJ/cm² is 0.003 to 0.008.
 4. The photoreactive polymer as claimed in claim 1, wherein the photoreactive polymer absorbs a polarized UV radiation having a wavelength of 270 to 340 nm.
 5. The photoreactive polymer as claimed in claim 1, wherein the absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to the polarized UV radiation at a total exposure dose of 500 mJ/cm² or more is maintained in the range of 0 to 0.00006.
 6. The photoreactive polymer as claimed in claim 5, wherein the absolute value of a variation in dichloric ratio per unit UV dose as given by d(dichloric ratio)/d(mJ/cm²) upon exposure to the light at a total exposure dose of 500 to 2,500 mJ/cm² is maintained in the range of 0 to 0.00006. 